FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

REGISTER

now for free

DM Canafax

Research Profile

Chemicals & Drugs

Procedures

Phenomena

Metabolic Clearance Rate

Occupations

Chemistry, Pharmaceutical

Concepts & Ideas

Register to see full profile

Co-author Network

Register to see all co-authors

Publications

TOP 3
DM Canafax; WD Irish; HB Moran; E Squiers; R Levy; P Pouletty; M Roy First; U Christians
An individual bioequivalence approach to compare the intrasubject variability of two ciclosporin formulations, SangCya and Neoral.
Robert A Fisher; Shi-Hui Pan; S J Rossi; TJ Schroeder; WD Irish; DM Canafax; Richard R Lopez
Pharmacokinetic comparison of two cyclosporine A formulations, SangCya (Sang-35) and Neoral, in stable adult liver transplant recipients.
Robert S Gaston; R R Alloway; A O Gaber; S J Rossi; TJ Schroeder; WD Irish; DM Canafax; M Roy First
Pharmacokinetic and safety evaluation of SangCya vs Neoral or Sandimmune in stable renal transplant recipients.

Register to see all publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Register to see more

Geonetwork of DM Canafax (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

1999: DM Canafax; WD Irish; HB Moran; E Squiers; R Levy; P Pouletty; M Roy First; U Christians
An individual bioequivalence approach to compare the intrasubject variability of two ciclosporin formulations, SangCya and Neoral.
Pharmacology 1999;59(2):78-88.
1999: Robert A Fisher; Shi-Hui Pan; S J Rossi; TJ Schroeder; WD Irish; DM Canafax; Richard R Lopez
Pharmacokinetic comparison of two cyclosporine A formulations, SangCya (Sang-35) and Neoral, in stable adult liver transplant recipients.
Transplantation proceedings 1999;31(1-2):394-5.
1999: Robert S Gaston; R R Alloway; A O Gaber; S J Rossi; TJ Schroeder; WD Irish; DM Canafax; M Roy First
Pharmacokinetic and safety evaluation of SangCya vs Neoral or Sandimmune in stable renal transplant recipients.
Transplantation proceedings 1999;31(1-2):326-7.
1999: M Roy First; Pat Weiskittel; M L Burton; MB Shah; D Dreyer; PR Fleck; C Bey; V Ram Peddi; DM Canafax; TJ Schroeder
Nine-month follow-up of SangCya (Sang-35) in kidney transplant patients after conversion from Sandimmune.
Transplantation proceedings 1999;31(1-2):324-5.
1998: M Roy First; Pat Weiskittel; M Shah; V Ram Peddi; DM Canafax; TJ Schroeder
Conversion of stable renal transplant recipients from Sandimmune to Sang-35, a Neoral-equivalent cyclosporine formulation, using a dose-adjusted method.
Transplantation proceedings 1998;30(8):3955-7.
1998: M Roy First; Pat Weiskittel; M Burton; M Shah; D Dreyer; PR Fleck; C Bey; R Peddi; DM Canafax; TJ Schroeder
Conversion of stable renal transplant recipients from Sandimmune to Sang-35, a novel cyclosporine formulation, using a dose-normalized equivalence method.
Transplantation proceedings 1998;30(5):1701-5.

Register to see more

Copyright © 2011 Elsevier Inc. All rights reserved.